Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$41.07 -0.16 (-0.39%)
As of: Oct 21, 2026 · 3:45 PM EDT

Supernus Pharmaceuticals (SUPN) Non-Current Debt (2011 - 2021)

Updated

Supernus Pharmaceuticals' Non-Current Debt was $379.25 million in Q4 2021.

Analysis

Supernus Pharmaceuticals (SUPN) Non-Current Debt (2011 - 2021) Analysis & Trends

From Q4 2011 onward, Supernus Pharmaceuticals has reported Non-Current Debt for 7 quarters.

  • The Q4 2021 figure marks the lowest quarterly Non-Current Debt since Q1 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,138.33 Bn 1,106.91 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 618.82 Bn 537.35 Bn 17.26 Bn 37.34 Bn
3 AbbVie 503.36 Bn 476.47 Bn 12.70 Bn 62.48 Bn
4 Merck 369.59 Bn 323.96 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.57 Bn 262.56 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.25 Bn 234.94 Bn 12.86 Bn 23.68 Bn
7 Amgen 237.35 Bn 192.75 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 191.27 Bn 165.47 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn 60.50 Bn
10 Supernus Pharmaceuticals 2.38 Bn 1.04 Bn 185.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 379.25 Mn
Mar 31, 2013 7.98 Mn
Dec 31, 2012 11.09 Mn
Sep 30, 2012 14.12 Mn
Jun 30, 2012 17.06 Mn
Mar 31, 2012 19.93 Mn
Dec 31, 2011 22.71 Mn
API Access

Supernus Pharmaceuticals Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=SUPN&period=max&api_key=YOUR_API_KEY